• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

former novartis rep

Anonymous

Guest
Sorry to hear the news about tekturna studies; unfortunate it will hurt the sales reps not some of the douche bag execs. Anyway, I launched tekturna and would love to be a part of any lawsuit that would bring to light the BS novartis made us do in regards to the sales pitch, etc during launch while using pips and other threatening management styles to enforce it. Anyone know of law firms working with novartis reps?
 




Sorry to hear the news about tekturna studies; unfortunate it will hurt the sales reps not some of the douche bag execs. Anyway, I launched tekturna and would love to be a part of any lawsuit that would bring to light the BS novartis made us do in regards to the sales pitch, etc during launch while using pips and other threatening management styles to enforce it. Anyone know of law firms working with novartis reps?

Yes, I do.